Literature DB >> 19052873

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Cao Yang1, Shuhua Yang, Kirkham B Wood, Francis J Hornicek, Joseph H Schwab, Gertrude Fondren, Henry Mankin, Zhenfeng Duan.   

Abstract

To identify apoptosis genes involved in the multidrug resistance of osteosarcoma, a multidrug resistant human osteosarcoma cell line (U-2 OS MR) was established. Apoptosis gene microarray analysis demonstrated that GADD45alpha was significantly induced in U-2 OS cells after exposure to paclitaxel (P < 0.0001). However, the induction of GADD45alpha did not occur in U-2 OS MR cells. Subsequent analysis by Western blot confirmed that the expression of GADD45alpha could be significantly induced by paclitaxel and doxorubicin in U-2 OS cells but not in U-2 OS MR cells. Furthermore, the paclitaxel or doxorubicin treated U-2 OS and KH OS cells have a higher percentage of apoptotic cells when compared with U-2 OS MR and KH OS R2 cells treated with the same drugs. When GADD45alpha was transfected into U-2 OS MR or KH OS R2 and expressed, the cells became more sensitive to chemotherapeutic drugs. These results suggest that GADD45alpha may play a role in drug-induced apoptosis, as well as multidrug resistance in osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19052873     DOI: 10.1007/s10495-008-0282-x

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  11 in total

1.  Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.

Authors:  Zhenfeng Duan; Edwin Choy; David Harmon; Cao Yang; Keinosuke Ryu; Joseph Schwab; Henry Mankin; Francis J Hornicek
Journal:  Mol Cancer Ther       Date:  2009-07-28       Impact factor: 6.261

2.  Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.

Authors:  Peng Xiu; Zongzhen Xu; Feng Liu; Ziqiang Li; Tao Li; Fang Zou; Xueying Sun; Jie Li
Journal:  Dig Dis Sci       Date:  2014-03-27       Impact factor: 3.199

3.  Histone deacetylase inhibitor PCI-24781 enhances chemotherapy-induced apoptosis in multidrug-resistant sarcoma cell lines.

Authors:  Cao Yang; Edwin Choy; Francis J Hornicek; Kirkham B Wood; Joseph H Schwab; Xianzhe Liu; Henry Mankin; Zhenfeng Duan
Journal:  Anticancer Res       Date:  2011-04       Impact factor: 2.480

Review 4.  GADD45 proteins: central players in tumorigenesis.

Authors:  R E Tamura; J F de Vasconcellos; D Sarkar; T A Libermann; P B Fisher; L F Zerbini
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

5.  Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.

Authors:  Keinosuke Ryu; Michiro Susa; Edwin Choy; Cao Yang; Francis J Hornicek; Henry J Mankin; Zhenfeng Duan
Journal:  BMC Cancer       Date:  2010-05-10       Impact factor: 4.430

6.  Carfilzomib inhibits the growth of lung adenocarcinoma via upregulation of Gadd45a expression.

Authors:  Fang Yang; Wang-Wang Liu; Hui Chen; Jia Zhu; Ai-Hua Huang; Fei Zhou; Yi Gan; Yan-Hua Zhang; Li Ma
Journal:  J Zhejiang Univ Sci B       Date:  2020 Jan.       Impact factor: 3.066

Review 7.  Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature.

Authors:  J PosthumaDeBoer; M A Witlox; G J L Kaspers; B J van Royen
Journal:  Clin Exp Metastasis       Date:  2011-04-02       Impact factor: 5.150

8.  miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.

Authors:  Zhenfeng Duan; Yan Gao; Jacson Shen; Edwin Choy; Gregory Cote; David Harmon; Karen Bernstein; Santiago Lozano-Calderon; Henry Mankin; Francis J Hornicek
Journal:  Mol Oncol       Date:  2016-10-24       Impact factor: 6.603

9.  Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene.

Authors:  Tale Barøy; Chandra S R Chilamakuri; Susanne Lorenz; Jinchang Sun; Øyvind S Bruland; Ola Myklebost; Leonardo A Meza-Zepeda
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

10.  Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Xin Wang; Fang Zou; Jingtao Zhong; Longtao Yue; Fuhai Wang; Honglong Wei; Guangsheng Yang; Tao Jin; Xiaofeng Dong; Jie Li; Peng Xiu
Journal:  J Cancer       Date:  2018-04-06       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.